Evidence map›Paper›PMID 29416537›Full record

ArticleFrontiers in immunology2018

Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1.

Kristofor K Ellestad, Govindarajan Thangavelu, Yohannes Haile, Jiaxin Lin, Louis Boon, Colin C Anderson

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. PD-1 cooperates with AIRE-mediated tolerance to prevent lethal autoimmune disease.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Kristofor K EllestadDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada.
Govindarajan ThangaveluAlberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.
Yohannes HaileAlberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.
Jiaxin LinAlberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.
Louis BoonBioceros B.V., Utrecht, Netherlands.
Colin C AndersonDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada.
University of Alberta · CAPolpharma Biologics (Netherlands) · NL

Funding

CIHR FRN79521CIHR PS148588
6 · The paper itself

Abstract

Lymphopenia can result from various factors, including viral infections, clinical interventions, or as a normal property of the fetal/neonatal period. T cells in a lymphopenic environment undergo lymphopenia-induced proliferation (LIP) to fill the available "niche" as defined by peptide-MHC and homeostatic cytokine resources. We recently reported systemic autoimmunity following reconstitution of the lymphoid compartment of Rag1

Indexed as

AutoimmunityPeripheral ToleranceAnimalsCD4-Positive T-LymphocytesDiabetes Mellitus, Experimentalfas ReceptorFemaleIslets of Langerhans TransplantationMaleMicePerforinProgrammed Cell Death 1 ReceptorFas protein, mousefas ReceptorPerforinProgrammed Cell Death 1 Receptorautoimmunitycheckpoint inhibitorco-inhibitionco-stimulationcytokine stormgraft versus hostlymphopeniatolerance

Identifiers

PMID29416537
PMCPMC5787554
OpenAlexW2789370709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.